Selected article for: "adaptive immune response and lymph node"

Author: Criscuolo, E.; Caputo, V.; Diotti, R. A.; Sautto, G. A.; Kirchenbaum, G. A.; Clementi, N.
Title: Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines
  • Document date: 2019_3_4
  • ID: 0xo2fiop_35
    Snippet: Immune Response. Another vaccine delivery route capable of triggering both systemic and mucosal immunities is the intradermal route, in which the antigen is delivered through the skin using recently developed self-administrable devices. In particular, the application of microneedle technology overcomes the skin permeation barrier imposed by the stratum corneum and facilitates antigen delivery. The efficacy of this new microneedle-based immunizati.....
    Document: Immune Response. Another vaccine delivery route capable of triggering both systemic and mucosal immunities is the intradermal route, in which the antigen is delivered through the skin using recently developed self-administrable devices. In particular, the application of microneedle technology overcomes the skin permeation barrier imposed by the stratum corneum and facilitates antigen delivery. The efficacy of this new microneedle-based immunization approach is due to the presence of several types of immune cells (such as DCs, T lymphocytes, NK cells, macrophages, and mast cells) in the epithelium [99, 100] . In fact, the cells that are responsible for triggering the inflammation cascade in the skin are the Langerhans cells (comprising 2-4% of epithelial cells). Langerhans cells are a specific DC subset that migrates into the lymph node following antigen capture and aids in the initiation of an adaptive immune response [101] . These cells are also efficiently stimulated by pathogen-associated molecular patterns (PAMPs) using an array of germlineencoded pattern recognition receptors (PRR), including toll-like receptors (TLR) and langerin (CD207) [100] . Importantly, skin resident mast cells are also key drivers of the innate immune response in the skin through the release of granules containing inflammatory mediators [102] .

    Search related documents:
    Co phrase search for related documents
    • adaptive immune response and DC subset: 1
    • adaptive immune response and epithelial cell: 1, 2, 3, 4, 5, 6, 7, 8
    • adaptive immune response and immune cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • adaptive immune response and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • adaptive immune response and immunization approach: 1, 2
    • adaptive immune response and inflammation cascade: 1, 2
    • adaptive immune response and intradermal route: 1
    • antigen delivery and epithelial cell: 1
    • antigen delivery and immune cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • antigen delivery and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antigen delivery and immunization approach: 1, 2
    • antigen delivery and intradermal route: 1
    • DC subset and immune cell: 1
    • DC subset and immune response: 1, 2
    • efficiently stimulate and immune response: 1, 2, 3
    • epithelial cell and immune cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • epithelial cell and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • epithelial cell and inflammatory mediator: 1, 2, 3, 4, 5
    • epithelial cell and key driver: 1, 2